Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.
Goldman Sachs Small/Mid Cap Value A GMVAX
- NAV / 1-Day Return 15.59 / +0.84 %
- Total Assets 144.4 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.170%
- Distribution Fee Level Average
- Share Class Type Front Load
- Category Mid-Cap Blend
- Investment Style Small Blend
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 0.60%
- Turnover 56%
USD | NAV as of May 04, 2024 | 1-Day Return as of May 04, 2024, 12:13 AM GMT+0
Morningstar’s Analysis GMVAX
Will GMVAX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 14.6
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Goldman Sachs FS Government Instl | 1.91 | 3.0 Mil | Cash and Equivalents |
Curtiss-Wright Corp | 1.70 | 2.6 Mil | Industrials |
Saia Inc | 1.65 | 2.6 Mil | Industrials |
Tenet Healthcare Corp | 1.60 | 2.5 Mil | Healthcare |
Entegris Inc | 1.47 | 2.3 Mil | Technology |
AECOM | 1.45 | 2.2 Mil | Industrials |
Regal Rexnord Corp | 1.44 | 2.2 Mil | Industrials |
KBR Inc | 1.39 | 2.2 Mil | Industrials |
SPX Technologies Inc | 1.38 | 2.1 Mil | Industrials |
ASGN Inc | 1.28 | 2.0 Mil | Technology |